234 related articles for article (PubMed ID: 8413244)
1. PU.1 is a component of a multiprotein complex which binds an essential site in the murine immunoglobulin lambda 2-4 enhancer.
Eisenbeis CF; Singh H; Storb U
Mol Cell Biol; 1993 Oct; 13(10):6452-61. PubMed ID: 8413244
[TBL] [Abstract][Full Text] [Related]
2. A novel enhancer in the immunoglobulin lambda locus is duplicated and functionally independent of NF kappa B.
Hagman J; Rudin CM; Haasch D; Chaplin D; Storb U
Genes Dev; 1990 Jun; 4(6):978-92. PubMed ID: 2116989
[TBL] [Abstract][Full Text] [Related]
3. PU.1 recruits a second nuclear factor to a site important for immunoglobulin kappa 3' enhancer activity.
Pongubala JM; Nagulapalli S; Klemsz MJ; McKercher SR; Maki RA; Atchison ML
Mol Cell Biol; 1992 Jan; 12(1):368-78. PubMed ID: 1729611
[TBL] [Abstract][Full Text] [Related]
4. Regulation of lymphoid-specific immunoglobulin mu heavy chain gene enhancer by ETS-domain proteins.
Nelsen B; Tian G; Erman B; Gregoire J; Maki R; Graves B; Sen R
Science; 1993 Jul; 261(5117):82-6. PubMed ID: 8316859
[TBL] [Abstract][Full Text] [Related]
5. A three-protein-DNA complex on a B cell-specific domain of the immunoglobulin mu heavy chain gene enhancer.
Rao E; Dang W; Tian G; Sen R
J Biol Chem; 1997 Mar; 272(10):6722-32. PubMed ID: 9045705
[TBL] [Abstract][Full Text] [Related]
6. Two conserved essential motifs of the murine immunoglobulin lambda enhancers bind B-cell-specific factors.
Rudin CM; Storb U
Mol Cell Biol; 1992 Jan; 12(1):309-20. PubMed ID: 1729607
[TBL] [Abstract][Full Text] [Related]
7. Quantitative hydroxyl radical footprinting reveals cooperative interactions between DNA-binding subdomains of PU.1 and IRF4.
Gross P; Yee AA; Arrowsmith CH; Macgregor RB
Biochemistry; 1998 Jul; 37(27):9802-11. PubMed ID: 9657694
[TBL] [Abstract][Full Text] [Related]
8. Assembly requirements of PU.1-Pip (IRF-4) activator complexes: inhibiting function in vivo using fused dimers.
Brass AL; Zhu AQ; Singh H
EMBO J; 1999 Feb; 18(4):977-91. PubMed ID: 10022840
[TBL] [Abstract][Full Text] [Related]
9. Effect of PU.1 phosphorylation on interaction with NF-EM5 and transcriptional activation.
Pongubala JM; Van Beveren C; Nagulapalli S; Klemsz MJ; McKercher SR; Maki RA; Atchison ML
Science; 1993 Mar; 259(5101):1622-5. PubMed ID: 8456286
[TBL] [Abstract][Full Text] [Related]
10. SPI-B activates transcription via a unique proline, serine, and threonine domain and exhibits DNA binding affinity differences from PU.1.
Rao S; Matsumura A; Yoon J; Simon MC
J Biol Chem; 1999 Apr; 274(16):11115-24. PubMed ID: 10196196
[TBL] [Abstract][Full Text] [Related]
11. Pip, a novel IRF family member, is a lymphoid-specific, PU.1-dependent transcriptional activator.
Eisenbeis CF; Singh H; Storb U
Genes Dev; 1995 Jun; 9(11):1377-87. PubMed ID: 7797077
[TBL] [Abstract][Full Text] [Related]
12. SPI-C, a PU-box binding ETS protein expressed temporarily during B-cell development and in macrophages, contains an acidic transactivation domain located to the N-terminus.
Carlsson R; Persson C; Leanderson T
Mol Immunol; 2003 Jun; 39(16):1035-43. PubMed ID: 12749910
[TBL] [Abstract][Full Text] [Related]
13. PU.1 and GATA: components of a mast cell-specific interleukin 4 intronic enhancer.
Henkel G; Brown MA
Proc Natl Acad Sci U S A; 1994 Aug; 91(16):7737-41. PubMed ID: 8052653
[TBL] [Abstract][Full Text] [Related]
14. cis-acting sequences required for inducible interleukin-2 enhancer function bind a novel Ets-related protein, Elf-1.
Thompson CB; Wang CY; Ho IC; Bohjanen PR; Petryniak B; June CH; Miesfeldt S; Zhang L; Nabel GJ; Karpinski B
Mol Cell Biol; 1992 Mar; 12(3):1043-53. PubMed ID: 1545787
[TBL] [Abstract][Full Text] [Related]
15. The sequence-specific association of the ETS domain of murine PU.1 with DNA exhibits unusual energetics.
Poon GM; Gross P; Macgregor RB
Biochemistry; 2002 Feb; 41(7):2361-71. PubMed ID: 11841229
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a myeloid-specific enhancer of the chicken lysozyme gene. Major role for an Ets transcription factor-binding site.
Ahne B; Strätling WH
J Biol Chem; 1994 Jul; 269(27):17794-801. PubMed ID: 8027033
[TBL] [Abstract][Full Text] [Related]
17. Mef2 proteins, required for muscle differentiation, bind an essential site in the Ig lambda enhancer.
Satyaraj E; Storb U
J Immunol; 1998 Nov; 161(9):4795-802. PubMed ID: 9794411
[TBL] [Abstract][Full Text] [Related]
18. Transactivation of the Moloney murine leukemia virus and T-cell receptor beta-chain enhancers by cbf and ets requires intact binding sites for both proteins.
Sun W; Graves BJ; Speck NA
J Virol; 1995 Aug; 69(8):4941-9. PubMed ID: 7609063
[TBL] [Abstract][Full Text] [Related]
19. The +37 kb Cebpa Enhancer Is Critical for Cebpa Myeloid Gene Expression and Contains Functional Sites that Bind SCL, GATA2, C/EBPα, PU.1, and Additional Ets Factors.
Cooper S; Guo H; Friedman AD
PLoS One; 2015; 10(5):e0126385. PubMed ID: 25938608
[TBL] [Abstract][Full Text] [Related]
20. Sequence-specific binding of human Ets-1 to the T cell receptor alpha gene enhancer.
Ho IC; Bhat NK; Gottschalk LR; Lindsten T; Thompson CB; Papas TS; Leiden JM
Science; 1990 Nov; 250(4982):814-8. PubMed ID: 2237431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
